Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Milan - Delayed Quote EUR

Edwards Lifesciences Corporation (1EW.MI)

66.62
+0.57
+(0.86%)
At close: April 7 at 2:24:16 PM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Bernard J. Zovighian CEO & Director 2.36M -- 1968
Mr. Scott B. Ullem Corporate VP & CFO 1.21M 1.95M 1967
Mr. Donald E. Bobo Jr. Corporate Vice President of Strategy & Corporate Development 1.2M 3.2M 1962
Mr. Larry L. Wood Corporate VP and Group President of TAVR & Surgical Structural Heart 1.33M -- 1966
Mr. Jean-Luc Lemercier Corporate Vice President of Japan, Asia Pacific & Greater China 1.26M 2M 1957
Mr. Daveen Chopra Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies 1.09M 169.27k 1979
Mr. Andrew M. Dahl Principal Accounting Officer, Senior VP & Corporate Controller -- -- 1977
Dr. Todd J. Brinton FACC, M.D. Corporate VP of Advanced Technology & Chief Scientific Officer -- -- --
Mr. Mark Wilterding Vice President of Investor Relations -- -- --
Mr. Arnold A. Pinkston J.D. Corporate VP & General Counsel -- -- 1959

Edwards Lifesciences Corporation

One Edwards Way
Irvine, CA 92614
United States
949 250 2500 https://www.edwards.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
15,800

Description

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Corporate Governance

Edwards Lifesciences Corporation’s ISS Governance QualityScore as of April 1, 2025 is 5. The pillar scores are Audit: 10; Board: 3; Shareholder Rights: 4; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 22, 2025 at 10:59 AM UTC - July 28, 2025 at 12:00 PM UTC

Edwards Lifesciences Corporation Earnings Date

Recent Events

Related Tickers